Lysosomal Acid Lipase Deficiency Clinical Trial
Official title:
Identification of Undiagnosed Lysosomal Acid Lipase Deficiency
Partners HealthCare maintains a Patient Data Registry (PDR) with information from all patient encounters at Partners HealthCare facilities. We intend to utilize the PDR to identify groups of patient who are of high clinical suspicion for undiagnosed lysosomal acid lipase deficiency. A group of potential participants will be identified through the PDR. Detailed records will be requested to further narrow to ideal participants based upon previously existing diagnoses and symptoms. Participants will be invited to partake in the study via a letter from their Partners care provider with supporting study details. Study participants will be evaluated in a one-time visit. A complete family and medical history will be collected. A physical exam will be performed, and up to 20cc of blood will be drawn. All participants will be notified of their disease status via letter and phone call from the study staff. If the study participant is diagnosed with LALD through this evaluation, proper follow-up recommendations and referrals will be provided. Our intent is to determine if existing patient data can successfully be utilized to aid in the identification of patients with rare genetic disease.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05687474 -
Baby Detect : Genomic Newborn Screening
|
||
| Recruiting |
NCT03984149 -
Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects)
|
||
| Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
| Recruiting |
NCT03564002 -
Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity
|
||
| Terminated |
NCT02926872 -
Screening for Lysosomal Acid Lipase Deficiency
|
N/A | |
| Terminated |
NCT01473875 -
Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102
|
Phase 2/Phase 3 | |
| Completed |
NCT01358370 -
A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype
|
N/A | |
| Completed |
NCT01371825 -
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency
|
Phase 2/Phase 3 | |
| Enrolling by invitation |
NCT05368038 -
ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
|
||
| Terminated |
NCT02193867 -
Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency
|
Phase 2 | |
| Completed |
NCT02112994 -
Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency
|
Phase 2 | |
| Completed |
NCT01528917 -
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
|
N/A | |
| Completed |
NCT01757184 -
Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) in Participants With Lysosomal Acid Lipase Deficiency
|
Phase 3 | |
| Recruiting |
NCT01633489 -
Lysosomal Acid Lipase (LAL) Deficiency Registry
|
||
| Terminated |
NCT02345421 -
A Study to Identify and Characterize LAL-D Patients in High-risk Populations
|
N/A | |
| Completed |
NCT01488097 -
Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency
|
Phase 2 | |
| Completed |
NCT01307098 -
Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency
|
Phase 1/Phase 2 | |
| No longer available |
NCT02376751 -
An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency
|
N/A |